The company's purpose is to develop and market pharmaceutical products for the diagnosis and treatment of rare diseases. It also distributes systems and software for the relevant application, research and development. Additionally, it trades in related third-party products and can assume representations. It is authorized to enter into all transactions and obligations, as well as to conclude contracts that are directly or indirectly related to the company's purpose or that are suitable to promote it. Furthermore, the acquisition, management and disposal of participations and real estate are also part of the company's purpose. The company is also empowered to establish branches and business premises in Switzerland and abroad.